Following the suspension of the Indian Indian Treaty, the contract after the terrorist attack Pahalgam Pakistan Pakistan by retrieving all trade with the new Delhi. This sudden stop caused the Pakistani health authorities to initiate the “readiness for emergency readiness” measures for the protection of pharmaceutical supplies, as the country relies on India for 30-40% of its pharmaceutical raw materials, including active pharmaceutical components (API) and advanced therapeutic products.
The Pakistani Regulatory Authority for Drugs (DRAP) confirmed that emergency plans were introduced, although no formal announcement has been issued so far about the impact of the prohibition on the pharmaceutical sector. Drag officials said preparations for such disruption began after the 2019 crisis and are now actively looking for alternative sources from China, Russia and several European nations to maintain basic drug supply, such as anti-rake vaccines, vaccines against leakage, cancer therapy and monoclonal antibodies.
Despite this effort, initiates and health experts, they warn against significant challenges unless immediate measures are carried out. The Ministry of Health has yet to receive an official directive that explains the status of pharmaceutical imports and concerns about critical deficiency in this industry. The situation is further complicated by a prosperous black market, where unregistered and unapproved medicines-are timely smuggled to Pakistan through Afghanistan, Iran, Dubai and across the eastern border. While these illegal channels fill in gaps that leave legal imports, they do not provide any quality or reliability guarantee.
In response to the delegation from the Association of Pharmaceutical Manufacturers of Pakistan (PPMA) appealed to the authorities in Islamabad for liberation from the ban on trade and claimed that many life products depend solely on Indian raw materials. PPMA also turned to the special Investment Facilitation Council (SIFC), which urged pharmaceutical and health -related health excluded from a ban on patient life protection.
Some experts suggest that this crisis could serve as a catalyst for Pakistan to invest in domestic production of API, vaccines and biological substances, reducing future relying to foreign suppliers.
(Tagstotranslate) Pakistan
